Cutler Group LP Spectrum Pharmaceuticals Inc Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 27, 2020	SELL	$2.99 - $4.9 $598 - $980	-200 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$3.5 - $10.35 $10,363 - $30,646	-2,961 Reduced 93.67%	200 $0
Q1 2018 May 11, 2018	BUY	$16.09 - $23.07 $1,609 - $2,307	100 Added 3.27%	3,161 $50,000
Q4 2017 Jan 17, 2018	BUY	$13.36 - $20.73 $40,894 - $63,454	3,061	3,061 $58,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.